Iovance Biotherapeutics, Inc. (IOVA) Insider Trading
Over the last 6 months, 239 institutions increased and 124 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Nov
May
Jun
Context3-month price -17.5%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 9, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Option | 7,813 | — |
| Jun 9, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Tax | 3,843 | $4.23 |
| Jun 9, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Tax | 3,976 | $4.23 |
| Jun 9, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Tax | 3,976 | $4.23 |
| Jun 9, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Option | 7,813 | — |
| Jun 9, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Option | 9,766 | — |
| Jun 9, 2026 | Vogt Frederick Gdirector, officer: Interim CEO & General Counsel | Tax | 6,638 | $4.23 |
| Jun 9, 2026 | Vogt Frederick Gdirector, officer: Interim CEO & General Counsel | Option | 15,625 | — |
| Jun 3, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Option | 5,469 | — |
| Jun 3, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Tax | 4,473 | $3.96 |
| Jun 3, 2026 | Vogt Frederick Gdirector, officer: Interim CEO & General Counsel | Option | 41,668 | — |
| Jun 3, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Option | 8,790 | — |
| Jun 3, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Option | 8,790 | — |
| Jun 3, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Tax | 2,508 | $3.96 |
| Jun 3, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Tax | 4,473 | $3.96 |
| Jun 3, 2026 | Vogt Frederick Gdirector, officer: Interim CEO & General Counsel | Tax | 17,701 | $3.96 |
| May 13, 2026 | Kirby Daniel Gordonofficer: Chief Commercial Officer | Option | 10,000 | — |
| May 13, 2026 | Kirby Daniel Gordonofficer: Chief Commercial Officer | Tax | 2,435 | $3.70 |
| Mar 11, 2026 | Kirby Daniel Gordonofficer: Chief Commercial Officer | Grant | 132,200 | — |
| Mar 11, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Grant | 58,750 | — |
| Mar 11, 2026 | Roche Corleen M.officer: Chief Financial Officer | Grant | 132,200 | — |
| Mar 11, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Grant | 117,500 | — |
| Mar 11, 2026 | Vogt Frederick Gdirector, officer: Interim CEO & General Counsel | Grant | 235,000 | — |
| Mar 11, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Grant | 117,500 | — |
| Mar 6, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Option | 31,246 | — |
| Mar 6, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Option | 39,059 | — |
| Mar 6, 2026 | GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical Officer | Tax | 16,520 | $4.58 |
| Mar 6, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Option | 31,246 | — |
| Mar 6, 2026 | Puri Raj K.officer: Chief Regulatory Officer | Tax | 18,360 | $4.58 |
| Mar 6, 2026 | BILINSKY IGORofficer: Chief Operating Officer | Tax | 16,628 | $4.58 |
Source: IOVA SEC Form 4 filings, latest Jun 9, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their IOVA positions over the last 6 months (SEC Form 13F).
Increased
239
New positions
110
Reduced
124
Sold out
76
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 31.1M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 29.5M | Feb 12, 2026 |
| MHR FUND MANAGEMENT LLC | Unchanged | 29.0M | Feb 17, 2026 |
| MHR FUND MANAGEMENT LLC | Unchanged | 29.0M | May 15, 2026 |
| VANGUARD GROUP INC | Increased | 27.2M | Jan 29, 2026 |
| STATE STREET CORP | Increased | 20.2M | Feb 13, 2026 |
| STATE STREET CORP | Reduced | 17.4M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 16.6M | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 14.3M | Feb 17, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 13.7M | May 15, 2026 |
| INVENOMIC CAPITAL MANAGEMENT LP | Increased | 12.0M | Feb 17, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 11.7M | May 8, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 9.4M | May 15, 2026 |
| MORGAN STANLEY | Increased | 9.2M | Feb 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 8.8M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.